Skip to content

Seaport Therapeutics SPTX Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

MYR Group logo
MYR GroupMYRG
$50.36M+18.9%
EPR Properties logo
EPR PropertiesEPR
$166.65M-7.7%
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
5.9%+0.1pp
CleanSpark logo
CleanSparkCLSK
$5.32M+20.1%
Mirion Technologies logo
Mirion TechnologiesMIR
5.4%+0.4pp
Eastern Bankshares, Inc. logo
Eastern Bankshares, Inc.EBC
4.4%0.0pp

Other financials

Income statement

See full
Operating income-$27.5M-70.2%
Net income-$25.4M-93.6%
EPS (diluted)-$10.34-83.0%

Balance sheet

See full
Cash & equivalents$52.9M
Total debt$5.3M
Total equity-$115.6M-220%
Total assets$227.7M

Cash flow

See full
Operating cash flow-$20.2M+0.2%
CapEx--100%
Free cash flow-$20.2M+0.4%

Valuation

See full
Market cap$972.65M
Enterprise value$925.08M

Returns & leverage

See full
Debt / equity-0×
Current ratio13.2×

Where this comes from

Reported directly by Seaport Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Seaport Therapeutics ’s 10-Q, filed June 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Seaport Therapeutics 's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Seaport Therapeutics 's operating lease ROU assets?
Seaport Therapeutics (SPTX) reported operating lease ROU assets of $5.07M in Q1 2026.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.